Advertisements

Ibuprofen-Grindeks

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Ibuprofen-Grindeks

Ibuprofen-Grindeks is a medication produced by Grindeks, containing the active ingredient Ibuprofen. It is fundamentally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Its primary function is to provide symptomatic relief from pain, inflammation, and fever by influencing the body's chemical response to illness or injury. The active substance, Ibuprofen, is a synthetic compound derived from propionic acid.


Quick Facts: Ibuprofen-Grindeks Identity

Property Description
Active ingredient Ibuprofen
Form Oral Solid Preparation (Tablet/Film-Coated Tablet)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relief from Pain, Inflammation, and Fever
Origin Synthetic Compound

Defining Ibuprofen-Grindeks and Its Therapeutic Purpose

Ibuprofen-Grindeks is a specific formulation of Ibuprofen, a globally recognized agent that is clinically recognized for its analgesic (pain-relieving), antipyretic (fever-reducing), and anti-inflammatory effects. The NSAID classification means the drug works by reversibly inhibiting cyclooxygenase (COX) enzymes, which reduces the body’s production of chemical mediators known as prostaglandins. This action is crucial for reducing inflammation-related symptoms by blocking the signals that cause swelling and pain.

The medicine is supplied as a single active ingredient product, typically an oral solid preparation intended for oral administration. This form is designed for systemic absorption, allowing it to provide body-wide relief. Ibuprofen is widely used as a first-line drug for symptomatic relief, often for discomfort associated with conditions like muscle strain. This capacity to manage pain, inflammation, and fever simultaneously differentiates it from pure analgesics.

Regulatory References

  1. Ibuprofen - StatPearls - NIH
Advertisements

What side effects are possible with Ibuprofen-Grindeks?

Adverse Reaction Scope

The most frequently reported adverse reactions for ibuprofen are gastrointestinal (GI) in nature. These commonly include dyspepsia, abdominal pain, nausea, vomiting, and diarrhea. Serious adverse events, which are less common, primarily involve the gastrointestinal and cardiovascular systems.

Serious Adverse Reactions

Regulatory warnings highlight the risk of serious, potentially fatal events, including gastrointestinal bleeding, ulceration, and perforation. Ibuprofen may also be associated with a small increased risk of serious arterial thrombotic events, such as myocardial infarction and stroke, particularly when used at high doses (e.g., 2400 mg/ day) or for long periods.

Less common but serious reactions also include severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), severe allergic reactions (anaphylaxis), and renal impairment (e.g., fluid retention, acute renal failure), especially in vulnerable patients. Other system-organ classes involved include the nervous system (e.g., aseptic meningitis, rare) and hepatobiliary system.

Safety Restrictions and Population-Specific Considerations

Dose- and Duration-Related Safety

The risk of both serious GI and cardiovascular thrombotic events is dose-dependent. Undesirable effects are minimized by using the lowest effective dose for the shortest duration necessary. High doses are generally avoided in patients with existing cardiovascular risk factors or established cardiovascular disease.

Contraindications and Cautions

Ibuprofen is contraindicated in patients with a history of hypersensitivity to NSAIDs, active peptic ulceration or hemorrhage, severe heart failure (NYHA Class IV), severe renal or hepatic failure, and during the last trimester of pregnancy. Caution is required in the elderly, as they have an increased frequency of adverse reactions, particularly fatal GI bleeding. Use during the first and second trimesters of pregnancy should be avoided unless clearly necessary. The medication should also be used with caution in patients with uncontrolled hypertension, existing GI disease (like Crohn's or ulcerative colitis), or systemic lupus erythematosus (SLE) due to the increased risk of aseptic meningitis.

Regulatory Safety Summary

The official safety information structurally emphasizes the primary risks—GI toxicity and arterial thrombotic potential—and dictates strict limitations on use in specific patient populations or at high doses. The overarching safety principle is to limit exposure (dose and duration) to mitigate the potential for these serious complications.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents detailing Ibuprofen overdose describe a range of documented toxicity manifestations. Initial signs may include gastrointestinal disturbances such as nausea, vomiting, and epigastric pain, alongside central nervous system effects like severe headache, dizziness, lethargy, and tinnitus. Because the active ingredient is an NSAID, the physiological systems affected include the Gastrointestinal, Renal, and Cardiovascular systems.

However, overdose can escalate to severe and life-threatening outcomes. These documented complications include major gastrointestinal hemorrhage, acute renal failure, metabolic acidosis, severe hypotension, and neurological events such as seizures and coma.

Regulators mandate a strict emergency response: Individuals must seek immediate medical attention and contact a Poison Control Center or emergency services right away upon any suspected overdose, even if initial symptoms are mild or absent. Treatment is described as strictly symptomatic and supportive, as no specific antidote is known for Ibuprofen toxicity.

Population-specific considerations officially note that elderly or debilitated patients, as well as those with pre-existing renal or hepatic impairment, face an increased susceptibility to severe toxicity.

Advertisements

Therapeutic Uses of Ibuprofen-Grindeks

What Ibuprofen-Grindeks Treats: Main Uses and Benefits

Ibuprofen-Grindeks is commonly used to provide supportive symptomatic relief across three primary domains: pain, inflammation, and fever. This medication is applicable in conditions characterized by periods of heightened symptoms. It is relevant for easing symptoms related to mild to moderate physical discomfort, such as headaches, toothaches, backaches, and menstrual cramps.


Symptomatic Support Across Key Domains

The medication is considered relevant in clinical settings where symptoms are related to inflammatory or irritative states, such as those experienced in rheumatoid arthritis and osteoarthritis. It offers symptomatic relief that helps address symptom clusters that may become disruptive, and is applied in addressing symptom clusters that include joint stiffness, swelling, and localized pain. It may help support patients during difficult episodes by easing distress and can assist with supporting functional stability.

It is commonly used as part of symptomatic management for conditions such as acute episodes of discomfort following injury, fever and body aches associated with the common cold or flu, and the recurring pain of primary dysmenorrhea. “It is commonly used to help with symptoms that create noticeable physiological strain, which may contribute to improved day-to-day comfort during periods of temporary physiological imbalance.”

Quick Fact: Symptom Relief for Inflammatory States and Fever
The medication is applied across domains where short-term symptomatic support is needed for acute, episodic discomfort, and supports the moderation of the symptomatic impact of both systemic fever and localized pain.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Ibuprofen-Grindeks?

The eligibility profile for Ibuprofen-Grindeks is defined by official population restrictions and prohibitions documented in regulatory sources.

Contraindications (Must Not Use): The medicine is contraindicated for patients with a known hypersensitivity to Ibuprofen or other NSAIDs, and those with active or recurrent gastrointestinal bleeding or ulcers. Use is also prohibited in cases of severe renal, hepatic, or heart failure (NYHA Class IV). Ibuprofen-Grindeks must not be used after Coronary Artery Bypass Graft (CABG) surgery or during the third trimester of pregnancy.

Restricted and Conditional Use: Use requires caution in patients with uncontrolled hypertension, pre-existing cardiovascular disease, or milder organ impairment. Older adults are classified as a restricted-use population due to increased risk of adverse reactions, requiring the lowest effective dose.

Age and Physiological Status: The medicine is generally approved for adults and adolescents. Pediatric use is typically established from a minimum age (e.g., ≥ 6 months), but is not established below this threshold. Use should be avoided from 20 weeks of pregnancy onward unless essential. Short-term, low-dose use is generally considered acceptable during breastfeeding.

Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Ibuprofen-Grindeks (Ibuprofen) interaction profile is defined by official regulatory documentation focusing on two primary concerns: the augmentation of bleeding risk and the alteration of co-administered drug levels. The combination with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 inhibitors, is formally contraindicated due to a significantly increased risk of gastrointestinal (GI) bleeding and ulceration. This risk is also compounded by concomitant use of Anticoagulants (e.g., Warfarin), Oral Corticosteroids, Anti-platelet Agents, and SSRIs.

Ibuprofen may also cause a reduction in the renal clearance of certain substances, officially leading to an increase in plasma levels and the potential for toxicity of medicines such as Lithium and Methotrexate. Furthermore, Ibuprofen can diminish the therapeutic effects of Antihypertensive medications (e.g., ACE Inhibitors, Diuretics).

To address Pharmacodynamic interference with low-dose Aspirin's antiplatelet effect, regulatory guidance establishes a timing constraint: Ibuprofen should be taken at least eight hours before or 30 minutes after immediate-release low-dose Aspirin. Population-specific cautions note that interaction risks, particularly GI bleeding, are generally heightened in the elderly.

Advertisements

Mechanism of Action

Mechanism of Action

Ibuprofen-Grindeks operates through the reversible, non-selective inhibition of Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2 isoforms. This targeted blockade restricts the initial step of the Arachidonic Acid Cascade, resulting in the restricted synthesis of eicosanoids, principally Prostaglandin E2 (PGE2).

At peripheral sites, the reduction in local PGE2 decreases the sensitization of nociceptive afferents. This action elevates the threshold of signal transmission, reducing the pathway's response to stimuli. Centrally, the inhibition of PGE2 synthesis within the hypothalamus counteracts the pyrogen-mediated signal that resets the body's core temperature set-point upward, consequently allowing the body’s homeostatic mechanisms to proceed with heat dissipation.

Advertisements

Dosage and Administration Information

How to Use Ibuprofen-Grindeks

Ibuprofen-Grindeks is an oral solid preparation (tablet or film-coated tablet) and must be used strictly according to the official administration instructions. The governing principle for use is to administer the lowest effective dose for the shortest duration necessary to control symptoms.


Official Administration Guidelines (Oral)

Instruction Detail
Route of Administration Oral administration only for this tablet formulation.
Dosing Schedule (Adults) Short-term relief: 200 mg to 400 mg per dose. The maximum daily dose for short-term, self-care use is generally 1200 mg. Prescription use (e.g., arthritis): Daily doses range from 1200 mg to 3200 mg, divided into 3 or 4 administrations.
Frequency and Interval Doses must be separated by a minimum of 4 to 6 hours, administered as needed up to the daily maximum.
Timing in Relation to Meals Recommended to be taken with or after food or milk to minimize potential gastrointestinal discomfort.
Administration Method Tablets must be swallowed whole with a glass of water. They should not be chewed, crushed, or sucked on to prevent local irritation.

Use Patterns and Adjustments

For short-term symptomatic relief, the medication should typically not be used for more than 3 days for fever or 10 days for pain unless directed by a healthcare professional.

Population Adjustments: For older adults and patients with mild to moderate renal or hepatic impairment, the lowest possible dose should be used for the shortest duration necessary, and clinical monitoring is advised. No specific dosage adjustment is required for the elderly, but caution is advised due to increased risk factors.

Advertisements

Recent Clinical Evidence

Ibuprofen-Grindeks: Recent Clinical Evidence

Clinical research on ibuprofen, the active ingredient in Ibuprofen-Grindeks, has focused primarily on its established use in managing pain, fever, and inflammation associated with various acute and chronic conditions.

Primary Indication: Acute and Chronic Pain

Studies consistently report that the use of ibuprofen for conditions such as rheumatoid arthritis and osteoarthritis is associated with significant reductions in pain intensity and improvements in physical function. For patients experiencing acute pain, such as dental pain or headache, randomized controlled trials (RCTs) have examined the effects compared to placebo and other analgesics.

  • Osteoarthritis: Long-term observational studies of NSAID use in osteoarthritis have reported reductions in pain severity on the Visual Analogue Scale (VAS) over time for patients continuing treatment. The tolerability profile during sustained use is a key focus of ongoing safety surveillance.
  • Low Back Pain: Research has explored the role of ibuprofen monotherapy and combination treatments in managing acute low back pain. Findings indicate that patients report a decrease in pain intensity and an improvement in lumbar spine mobility following treatment, though the degree of effect can vary.

Expanded Areas of Investigation

Beyond the core indications, research continues to investigate the drug's properties in other clinical contexts, maintaining a focus on safety and efficacy markers.

  • Topical vs. Oral: Comparative research has been conducted to determine the equivalence of topical and oral ibuprofen preparations for chronic pain, such as in older adults with knee pain. These studies monitor the effects on pain and disability scores while comparing the reported frequency of adverse events.
  • Combination Therapies: The combination of ibuprofen with paracetamol has been investigated in trials for conditions like acute low back pain, with results reporting potential differences in pain relief duration and functional improvement compared to ibuprofen used alone. Research protocols specified that patients did not combine ibuprofen with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Key Studies & References

  1. Non-steroidal anti-inflammatory drugs for acute low back pain (Cochrane Review)
  2. Ibuprofen + Paracetamol - 200 mg + 325 mg Tablet - NON-STEROIDAL ANTI-INFLAMMATORY DRUG (Regulatory Document/PIL)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ibuprofen-Grindeks (FAQ)


Q: How quickly does Ibuprofen-Grindeks usually start to work?

According to the official product information, peak serum levels of the active ingredient are generally reached one to two hours after taking the oral tablet. This timeframe indicates when the highest level of the active ingredient is generally reached in the bloodstream.


Q: How long do the effects of Ibuprofen-Grindeks last?

Regulatory documents state that doses of Ibuprofen are generally administered with an interval of four to six hours as necessary for pain or fever relief. Dosing intervals are based on the expected time required between doses to maintain relief.


Q: What are the most common side effects listed for Ibuprofen-Grindeks?

The official product information lists the most commonly reported side effects as gastrointestinal issues. These may include nausea, vomiting, diarrhea, indigestion (dyspepsia), and discomfort in the abdominal area.


Q: Is it normal to feel a bit dizzy after taking Ibuprofen-Grindeks?

Official documentation describes dizziness as an undesirable effect that may occur while using the medication. This effect is noted in the product’s adverse effects section, which describes potential changes to the central nervous system.


Q: Are there any known interactions between Ibuprofen-Grindeks and alcohol?

Official drug interaction information describes that combining ibuprofen with alcohol increases the risk of serious gastrointestinal events, specifically stomach bleeding.


Q: Does taking Ibuprofen-Grindeks on an empty stomach increase the chance of side effects?

Official guidance suggests taking the medication with food or milk. This administration method is described as one way to minimize potential gastrointestinal discomfort.


Q: Are there different strengths of Ibuprofen-Grindeks available?

Ibuprofen is made available in tablets of multiple strengths, typically including 200 mg, 400 mg, 600 mg, and 800 mg depending on the specific product and market. The classification (OTC or prescription-only) is based on the specific strength of the tablet, as defined by regulatory standards.


Q: Is there a maximum number of days Ibuprofen-Grindeks should be used for common pain?

Official sources state that for short-term, self-care relief, the medication should generally not be used for more than 10 days for pain or 3 days for fever. The drug label describes these time limits for self-care, and use beyond this duration requires professional assessment.


Q: What is the difference between Ibuprofen-Grindeks and naproxen? (High-level comparison)

Both Ibuprofen and Naproxen are classified as Nonsteroidal Anti-inflammatory Drugs (NSAIDs). They share the same basic mechanism of action, which involves inhibiting cyclooxygenase enzymes to reduce pain and inflammation.


Q: Can Ibuprofen-Grindeks be taken with antacids?

There is no widely reported clinically significant interaction between standard antacids and ibuprofen in official regulatory documents. However, certain types of antacids may affect how the body absorbs the active ingredient.


Q: What is the general evidence theme regarding long-term use of NSAIDs like Ibuprofen-Grindeks?

Regulatory safety information emphasizes that the risk of serious side effects, including cardiovascular events and gastrointestinal bleeding, increases with the duration of use. Risk mitigation is achieved by limiting both the amount and the duration of use.


Q: Is Ibuprofen-Grindeks available over-the-counter or only by prescription?

Ibuprofen is available in certain lower strengths for over-the-counter (OTC) use without a prescription. Higher strengths, such as 600 mg and 800 mg tablets, are designated in official documents as prescription-only products.


Q: Does Ibuprofen-Grindeks contain gluten or lactose?

The official label for a specific ibuprofen product includes a full list of inactive ingredients. The inactive components, such as fillers and coatings, may include substances like starch or lactose depending on the manufacturer and specific formulation.


Q: What are the restrictions on using Ibuprofen-Grindeks during pregnancy?

The medicine is strictly contraindicated (must not be used) during the third trimester of pregnancy. Official guidelines state that use during the first and second trimesters is restricted and should be avoided unless professional necessity is established.


Q: Can Ibuprofen-Grindeks affect fertility?

Studies have examined the potential for drugs that work by inhibiting prostaglandin synthesis to affect female fertility by influencing ovulation. This effect is described as being reversible upon the withdrawal of the treatment.


Q: What official documents describe the proper conditions for using Ibuprofen-Grindeks?

The proper conditions for use, including warnings and administration details, are legally defined in authoritative regulatory documents. These include the Summary of Product Characteristics (SmPC) from the European Medicines Agency (EMA) and the FDA/NIH DailyMed labels.


Q: What is the meaning of 'Grindeks' in the drug name?

'Grindeks' refers to the pharmaceutical company that holds the marketing authorization for this specific formulation of the medicine. It designates the brand name and manufacturer of the product.


Q: Can Ibuprofen-Grindeks affect a person's ability to drive?

Official product information notes that ibuprofen can be associated with central nervous system effects like dizziness and somnolence (drowsiness). Regulatory guidance recommends caution before operating a vehicle or machinery.


Q: What is the difference between a side effect and an allergic reaction to Ibuprofen-Grindeks?

A side effect is an undesirable event that has been reported, such as nausea or abdominal pain. An allergic reaction, or hypersensitivity, is an immune response that can range from hives to severe, life-threatening reactions like anaphylaxis, and is listed as a contraindication.


Q: Does Ibuprofen-Grindeks have a sedative effect?

The regulatory documents list somnolence, which is the term for drowsiness, and the listing of this effect indicates that a sedative effect has been reported in official product documents.


Q: Are there any specific lifestyle habits mentioned in official sources that interact with Ibuprofen-Grindeks?

Official guidance describes the interaction risk associated with alcohol consumption, noting it is linked to an increased risk of serious gastrointestinal events when taken with ibuprofen.


Q: Is Ibuprofen-Grindeks chemically different from other forms of ibuprofen?

The active ingredient in all standard formulations is the synthetic compound ibuprofen (a propionic acid derivative). Chemical differences typically only exist in the specific salt form used or the non-active ingredients, such as coatings and fillers.


Q: Can Ibuprofen-Grindeks affect the liver?

Ibuprofen is strictly contraindicated for patients with severe hepatic failure (severe liver failure). Official warnings note that elevations of liver enzymes have been reported in some cases, and caution is required for patients with pre-existing liver issues.


Q: What regulatory agency approved Ibuprofen-Grindeks?

Ibuprofen-Grindeks is approved by the national or regional regulatory bodies where it is sold, such as the European Medicines Agency (EMA) or specific national agencies. These authorities grant the marketing authorization after reviewing the safety and quality data.


Q: Does Ibuprofen-Grindeks have any effect on sleep?

The regulatory documents list both somnolence (drowsiness) and insomnia (difficulty sleeping) as undesirable effects that have been reported. Effects on sleep can vary among individuals using the medication.


Q: What information is available about Ibuprofen-Grindeks use while breastfeeding?

Ibuprofen passes into breast milk in low concentrations. For short-term treatment at lower doses, official sources indicate that no known harmful effects to infants have been reported, and interruption of breastfeeding is not typically recommended in the product label.

Advertisements

How should Ibuprofen-Grindeks be stored and disposed of?

Storage and Disposal of Ibuprofen-Grindeks

Official Storage Requirements

Ibuprofen-Grindeks tablets must be stored according to the conditions specified on the regulatory labeling. The product should generally not be stored above 25 C or 30 C and must be kept in the original container or outer carton to protect it from light and moisture. The medicine is required to be stored out of the sight and reach of children.

Product Stability and Handling

Use of the medication is prohibited after the expiry date printed on the packaging. The solid tablet form does not typically require special handling conditions like refrigeration, but must be kept within the mandated temperature range.

Disposal Instructions

Any unused or expired medicinal product or waste material must be disposed of in accordance with local requirements. Official guidelines typically advise against disposal via household waste or wastewater and may recommend returning the leftover tablets to a pharmacist for proper pharmaceutical waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibuprofen-Grindeks found in:

A-Z Index: